Literature DB >> 16413501

Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo.

Xiaoling Zhang1, Changlong Yu, Chao Zhang, Tingting Tang, Kerong Dai.   

Abstract

Chitosan vector system is expected to be useful for direct gene therapy for joint disease. This study first sought to confirm that foreign genes can be transferred to articular chondrocytes in primary culture. Next, chitosan-DNA nanoparticles containing IL-1Ra or IL-10 gene were injected directly into the knee joint cavities of osteoarthritis rabbits to clarify the in vivo transfer availability of the chitosan vectors. Clear expression of IL-1Ra was detected in the knee joint synovial fluid of the chitosan IL-1Ra-injected group. While no expression was detected in the chitosan IL-10-injected group, this demonstrates that the transfection efficiency of chitosan-DNA nanoparticles was closely related to the type of the gene product. A significant reduction was also noted in the severity of histologic cartilage lesions in the group that received the chitosan IL-1Ra injection. This avenue may therefore represent a promising future treatment for osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413501     DOI: 10.1016/j.bbrc.2005.12.171

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Biomechanical signals suppress proinflammatory responses in cartilage: early events in experimental antigen-induced arthritis.

Authors:  Mario Ferretti; Robert Gassner; Zheng Wang; Priyangi Perera; James Deschner; Gwendolyn Sowa; Robert B Salter; Sudha Agarwal
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

Review 2.  Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration.

Authors:  Wenyi Gu; Chengtie Wu; Jiezhong Chen; Yin Xiao
Journal:  Int J Nanomedicine       Date:  2013-06-25

3.  Efficient Nonviral Gene Therapy Using Folate-Targeted Chitosan-DNA Nanoparticles In Vitro.

Authors:  Christian Jreyssaty; Qin Shi; Huijie Wang; Xingping Qiu; Françoise M Winnik; Xiaoling Zhang; Kerong Dai; Mohamed Benderdour; Julio C Fernandes
Journal:  ISRN Pharm       Date:  2012-03-07

4.  Chitosan-graft-polyethylenimine/DNA nanoparticles as novel non-viral gene delivery vectors targeting osteoarthritis.

Authors:  Huading Lu; Yuhu Dai; Lulu Lv; Huiqing Zhao
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

Review 5.  Gene therapy of the rheumatic diseases: 1998 to 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

Review 6.  Gene therapy for arthritis.

Authors:  Russell S Traister; Raphael Hirsch
Journal:  Mod Rheumatol       Date:  2008-01-05       Impact factor: 3.023

7.  Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation.

Authors:  Huading Lu; Lulu Lv; Yuhu Dai; Gang Wu; Huiqing Zhao; Fucheng Zhang
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

8.  Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1β.

Authors:  Susan E Lacy; Chengbin Wu; Dominic J Ambrosi; Chung-Ming Hsieh; Sahana Bose; Renee Miller; Donna M Conlon; Edit Tarcsa; Ravi Chari; Tariq Ghayur; Rajesh V Kamath
Journal:  MAbs       Date:  2015       Impact factor: 5.857

9.  Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta.

Authors:  Rong-Hui Deng; Bo Qiu; Pang-Hu Zhou
Journal:  J Mater Sci Mater Med       Date:  2018-10-01       Impact factor: 3.896

Review 10.  Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy.

Authors:  Longfa Kou; Shuyi Xiao; Rui Sun; Shihui Bao; Qing Yao; Ruijie Chen
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.